Home

"Targeted Locus Amplification enables fast identification of new chromosomal rearrangements and genomic breakpoint sequences in human T-ALL and unraveled a higher complexity of chromosomal translocations of known T-ALL oncogenes as thus far appreciated.”

Ghent University
Prof. Dr. Pieter van Vlierberghe - Center for Medical Genetics

"We use TLA to sequence gene fusions and other rearrangements in genes of interest. We have been impressed by the quality of TLA and Cergentis' work and are testing the use of identified breakpoint sequences as targets for personalised minimal residual disease tests."

Princess Máxima Center for Pediatric Oncology
Dr. Roland Kuiper - PI

"Cergentis quickly determined transgene insertion for three out of three lines along with providing information on deletions and rearrangements in chromosomal DNA at the site. The service was quick, accurate and reasonably priced, and reports were complete and helpful.”

Harvard University
Prof. Dr. Joshua Sanes - Department of Molecular and Cellular Biology
  • Latest news

  • Empowering advanced genetic engineering
    &
    precision medicine

  • Upcoming events

    11 | 3 | 2021 - Conferences
    Read more
    15 | 4 | 2021 / 16 | 4 | 2021 - Conferences
    Read more
  • APPNOTES

    Read more
  • TLA technology

    Read more
  • Publications

    Read more
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT